Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Equity (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Return on Equity for 15 consecutive years, with 0.11% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 16.0% to 0.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.11% through Dec 2025, up 16.0% year-over-year, with the annual reading at 0.12% for FY2025, 13.0% up from the prior year.
  • Return on Equity hit 0.11% in Q4 2025 for Cumberland Pharmaceuticals, up from 0.12% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.06% in Q1 2021 to a low of 0.43% in Q3 2024.
  • Historically, Return on Equity has averaged 0.09% across 5 years, with a median of 0.0% in 2023.
  • Biggest five-year swings in Return on Equity: plummeted -43bps in 2024 and later skyrocketed 31bps in 2025.
  • Year by year, Return on Equity stood at 0.04% in 2021, then crashed by -71bps to 0.01% in 2022, then tumbled by -1613bps to 0.2% in 2023, then crashed by -40bps to 0.27% in 2024, then surged by 59bps to 0.11% in 2025.
  • Business Quant data shows Return on Equity for CPIX at 0.11% in Q4 2025, 0.12% in Q3 2025, and 0.1% in Q2 2025.